Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hisanori Abe.
Alimentary Pharmacology & Therapeutics | 2002
Kazunari Murakami; Ryugo Sato; Tadayoshi Okimoto; Masaru Nasu; Toshio Fujioka; Masaaki Kodama; Jiro Kagawa; Shunzo Sato; Hisanori Abe; Tsuyoshi Arita
Background : The resistance of Helicobacter pylori to clarithromycin has become one of the primary reasons for eradication failure.
Journal of Gastroenterology | 2005
Hisanori Abe; Kazunari Murakami; Shunzo Satoh; Ryugo Sato; Masaaki Kodama; Tsuyoshi Arita; Toshio Fujioka
BackgroundTwo main pathogenic factors, bile reflux and Helicobacter pylori infection, have been identified in the remnant stomach, but it is still unclear which factor is important in the pathogenesis of gastritis in the remnant stomach after distal gastrectomy.MethodsIn 184 patients who had had distal gastrectomy performed using the Billroth-I procedure (B-I; n-106), Billroth-II procedure (B-II; n-36), and jejunal interposition (J-I; n-42) we examined the severity of remnant gastritis endoscopically and carried out examinations for H. pylori infection and histological examination.ResultsThe endoscopic severity of remnant gastritis was grade 1 or more in 101 of the 106 B-I patients (95.3%) and in all 36 B-II patients (100%). But, of the 42 J-I patients, the grade was 0 in 33 (78.6%). The endoscopic severity of remnant gastritis was significantly milder for J-I than for B-I (P < 0.001) and B-II (P < 0.001). H. pylori infection was confirmed in 59 of the 106 B-I patients (55.6%), 21 of the 36 B-II patients (58.3%), and 32 of the 42 J-I patients (76.1%). The rate of H. pylori infection was higher for J-I patients than for B-I (P < 0.05), but not for B-II patients (P = 0.1495). The severity of chronic and active inflammatory cellular infiltration tended to be inverse proportional relation with the endoscopic severity of the remnant gastritis. Furthermore, the histological inflammation and activity scores of H. pylori-positive patients were higher than those of H. pylori-negative patients, without regard to the endoscopic grade of gastritis.ConclusionsReconstruction techniques play an important role in the prevention of bile reflux, and we found that endoscopically more severe remnant gastritis was associated with a lower rate of H. pylori infection and with a lower degree of inflammatory cellular infiltration.
Scandinavian Journal of Gastroenterology | 2013
Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Hisanori Abe; Ryugo Sato; Ryo Ogawa; Kazuhiro Mizukami; Seiji Shiota; Yoshifumi Nakagawa; Wataru Soma; Tsuyoshi Arita; Toshio Fujioka
Abstract Objective. Although Helicobacter pylori (H. pylori) eradication has been shown to inhibit gastric cancer, it does not completely suppress it. Therefore, risk factors of gastric cancer development following H. pylori eradication were examined. Material and methods. A total of 2355 patients (1501 males and 824 females) underwent successful eradication of H. pylori. Endoscopic atrophy, histological gastritis, atrophy, intestinal metaplasia (IM), and operative link for gastritis assessment (OLGA) staging were subsequently evaluated. Results. Following eradication, 33/2355 patients (25 males and 8 females) developed gastric cancer. Compared to a nongastric cancer group that was matched according to gender and age, the incidence of endoscopic atrophy (3.52 ± 1.45 vs. 4.85 ± 1.18, p < 0.001), histological atrophy at the greater curvature of the antrum (1.42 ± 0.80 vs. 1.95 ± 0.86, p = 0.0059), inflammation (2.05 ± 0.59 vs. 2.33 ± 0.66, p = 0.031), IM at the greater curvature of the corpus (0.06 ± 0.30 vs. 0.24 ± 0.54, p = 0.029), the ratio of OLGA-stage 0–II/III, IV (13/8 vs. 55/11, p = 0.038) were significantly higher for the gastric cancer group. Multivariate analysis also showed the highest odds ratio (6.26, 95% confidence interval or CI, 1.28–30.60, p = 0.023) for IM at the greater curvature of the corpus. Conclusions. Severe endoscopical atrophy, OLGA staging, histological atrophy at the antrum, inflammation, and particularly IM at the corpus, were identified as risk factors for gastric cancer development following H. pylori eradication. Therefore, eradication should be performed before these predictors develop.
Radiation Medicine | 2008
Masaki Wakisaka; Mitsutaka Shuto; Hisanori Abe; Masaaki Tajima; Hidefumi Shiroshita; Toshio Bandoh; Tsuyoshi Arita; Michio Kobayashi; Tomoko Nakayama; Fumito Okada; Hiromu Mori; Naoki Uemura
We report a case of gastrointestinal manifestation of hereditary angioedema. Computed tomography (CT) revealed wall thickening of the gastric antrum, duodenum, and jejunum. Dilatation of the third part of the duodenum, thickening of the small bowel mesentery and omentum, and retroperitoneal edema were present. The importance of considering this condition in patients presenting such CT findings correlated with the appropriate history is discussed.
Scandinavian Journal of Gastroenterology | 2011
Kazunari Murakami; Tadayoshi Okimoto; Masaaki Kodama; Jin Tanahashi; Kazuhiro Mizukami; Mitsutaka Shuto; Hisanori Abe; Tsuyoshi Arita; Toshio Fujioka
Abstract Objective. Helicobacter pylori eradication therapy alone cannot heal gastric ulcers in Japanese patients. Irsogladine has previously been shown to accelerate the healing of gastric ulcers after H. pylori eradication therapy. And we previously reported that histamine H2 receptor antagonists inhibit gastric ulcer relapse after H. pylori eradication therapy. We therefore compared the efficacy of irsogladine with famotidine as appropriate treatments for ulcers after eradication therapy. Methods. Gastric ulcer patients with H. pylori infection (n = 119) were randomized to treatment with irsogladine 4 mg/day (n = 60) or famotidine 40 mg/day (n = 59) following 1-week H. pylori eradication therapy. After treatment, assessments of gastric ulcer healing were performed. Results. The ulcer healing rates in patients receiving irsogladine and famotidine were 85.2% (46/54) and 79.6% (43/54), respectively, and were not significantly different (p = 0.4484). In the famotidine group, the healing rate was significantly lower in patients who drink alcohol than in those who do not (60.0% vs. 91.2%; p = 0.0119). However, in the irsogladine group the healing rate did not differ between patients who drink alcohol and those who do not. Furthermore, the healing rate in smokers was significantly higher in the irsogladine group (88.0%) than in the famotidine group (59.1%) (p = 0.0233). Conclusions. Irsogladine and famotidine are both acceptable in treatment after H. pylori eradication therapy in gastric ulcer patients. Findings also suggest that irsogladine is more beneficial than famotidine in patients who drink alcohol and smoke.
Digestion | 2018
Masaaki Kodama; Tadayoshi Okimoto; Kazuhiro Mizukami; Hisanori Abe; Ryo Ogawa; Kazuhisa Okamoto; Mitsutaka Shuto; Osamu Matsunari; Yuka Hirashita; Ryugo Sato; Takashi Abe; Takayuki Nagai; Tsuyoshi Arita; Kazunari Murakami
Background/Aims: The rate of gastric cancer (GC) after Helicobacter pylori eradication has gradually increased; therefore, we investigate the clinicopathological features of GC following eradication in comparison with those of GC with H. pylori infection. Methods: This study included 50 subjects with GC after eradication (GCE) and 151 patients with GC with H. pylori infection (GCI). Clinicopathological factors were assessed. The manifestation of GC was further evaluated using immunohistochemical analysis and in situ hybridization. Results: Macroscopic analysis revealed a significantly higher ratio of depressed type /elevated type in the GCE compared with the GCI (30/19 vs. 61/77, p = 0.041). The gastric phenotype was more common in the GCE compared with the GCI, and the proportion of CDX2-positive cases was lower in the GCE (8 out of 18; 44.4%) compared with the GCI (18 out of 19; 94.7%; p = 0.00082). Ki-67 labeling index was significantly lower in the GCE (32.03 ± 22.15) compared with the GCI (79.20 ± 14.87, p < 0.0001). No patient in the GCE showed evidence of Epstein-Barr virus infection. Conclusion: The clinicopathological characteristics of GC following H. pylori eradication differ from those of GC in patients with H. pylori infection in terms of morphology, mucin phenotype, and proliferation rate.
Journal of bronchology & interventional pulmonology | 2010
Masaki Wakisaka; Wataru Sohma; Hisanori Abe; Yuichiro Kawano; Shigeo Ninomiya; Toshio Bandoh; Tsuyoshi Arita; Michio Kobayashi; Fumito Okada; Hiromu Mori
Multiple tracheal diverticula are rare. We report a case of a 62-year-old man who had multiple tracheal diverticula that were detected using multidetector-row computed tomography. Axial computed tomography images showed multiple air collections contiguous to the trachea. The multiple air collections were visible as outpouchings of the parts of the trachea between the cartilages, being located almost symmetrically on both lateral sides of the tracheal wall as seen on coronal multiplanar reconstruction images. Virtual bronchoscopy confirmed the presence of multiple openings in the tracheal wall of the diverticular necks. The alteration of the airway was better seen using volume-rendered reconstruction. Thin-slice multidetector-row computed tomography and advanced imaging techniques may increase the frequency of identification of multiple tracheal diverticula.
Journal of Cardiovascular Medicine | 2012
Masaki Wakisaka; Mitsutaka Shuto; Hisanori Abe; Shigeo Ninomiya; Hidefumi Shiroshita; Toshio Bandoh; Tsuyoshi Arita; Michio Kobayashi; Fumito Okada; Hiromu Mori
To the Editor Aneurysm of the azygos arch is a rarely described abnormality. This condition is often incidentally detected on routine chest radiographs or computed tomography (CT) obtained for another purpose. Intravenous dynamic contrast-enhanced CT (CE-CT) plays an important role in the diagnosis of this phenomenon. CT findings have already been reported in the English-language literature. We report herein the first case of an azygos arch aneurysm in which fluid–fluid layers formed by blood and injected contrast material were observed using CE-CT, together with a review of the literature.
Internal Medicine | 2002
Yoshikuni Kudo; Hideo Terao; Tsuyoshi Arita; Hisanori Kawasaki; Shunzo Sato; Hisanori Abe; Masaaki Kodama; Toshio Fujioka; Kazunari Murakami; Masaru Nasu
Journal of Gastroenterology | 2018
Yoshikazu Kinoshita; Mototsugu Kato; Mitsuhiro Fujishiro; Hironori Masuyama; Ryo Nakata; Hisanori Abe; Shinji Kumagai; Yasushi Fukushima; Yoshiumi Okubo; Seiichiro Hojo; Motoyasu Kusano